Contribution of platelets to tumour metastasis

[1]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[2]  Winnie Yang,et al.  Nucleotide‐binding domain of phosphoglycerate kinase 1 reduces tumor growth by suppressing COX‐2 expression , 2010, Cancer science.

[3]  Vanina A Medina,et al.  Histamine receptors and cancer pharmacology , 2010, British journal of pharmacology.

[4]  Darren R. Williams,et al.  Tumor‐stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7 , 2010, International journal of cancer.

[5]  J. Folkman,et al.  Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. , 2010, Blood.

[6]  L. Borsig,et al.  Selectins promote tumor metastasis. , 2010, Seminars in cancer biology.

[7]  Kohei Miyazono,et al.  TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.

[8]  R. Dhir,et al.  Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. , 2010, Cancer research.

[9]  Crislyn D'Souza-Schorey,et al.  Microvesicles: mediators of extracellular communication during cancer progression , 2010, Journal of Cell Science.

[10]  M. Schön,et al.  Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. , 2010, Blood.

[11]  W. Ruf,et al.  Tissue factor in cancer progression and angiogenesis. , 2010, Thrombosis research.

[12]  J. Freyssinet,et al.  Formation of procoagulant microparticles and properties. , 2010, Thrombosis research.

[13]  Chungho Kim,et al.  The final steps of integrin activation: the end game , 2010, Nature Reviews Molecular Cell Biology.

[14]  J. Freyssinet,et al.  Membrane microvesicles: macromessengers in cancer disease and progression. , 2010, Thrombosis research.

[15]  M. Bollen,et al.  Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts , 2010, PloS one.

[16]  G. Salvesen,et al.  Targeting activated integrin αvβ3 with patient-derived antibodies impacts late-stage multiorgan metastasis , 2010, Clinical & Experimental Metastasis.

[17]  P. Fraser,et al.  Regulation of Cerebromicrovascular Permeability by Lysophosphatidic Acid , 2010, Microcirculation.

[18]  K. Spanaus,et al.  Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes. , 2009, Blood.

[19]  H. Dauerman,et al.  Platelet functions beyond hemostasis , 2009, Journal of thrombosis and haemostasis : JTH.

[20]  P. Koumoutsakos,et al.  Tumorigenesis and Neoplastic Progression Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels , 2009 .

[21]  A. Khorana,et al.  Cancer, clots and consensus: new understanding of an old problem. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Khorana,et al.  Assessing risk of venous thromboembolism in the patient with cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  S. Russell,et al.  Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models , 2009, Journal of thrombosis and haemostasis : JTH.

[24]  N. Mukaida,et al.  Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. , 2009, Cancer research.

[25]  H. Salih,et al.  Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. , 2009, Cancer research.

[26]  D. Wagner,et al.  Tumorigenesis and Neoplastic Progression Innate Immune Cells Induce Hemorrhage in Tumors during Thrombocytopenia , 2010 .

[27]  S. Oudard,et al.  Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. , 2009, European urology.

[28]  R. Montironi,et al.  Editorial comment on: Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. , 2009, European urology.

[29]  D. Lombardo,et al.  Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo , 2009, The Journal of experimental medicine.

[30]  D. Wagner,et al.  Platelets: guardians of tumor vasculature. , 2009, Cancer research.

[31]  Konstantinos Konstantopoulos,et al.  Cancer cells in transit: the vascular interactions of tumor cells. , 2009, Annual review of biomedical engineering.

[32]  S. Mousa,et al.  Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence , 2009, Thrombosis and Haemostasis.

[33]  B. Felding-Habermann,et al.  Activation of tumor cell integrin αvβ3 controls angiogenesis and metastatic growth in the brain , 2009, Proceedings of the National Academy of Sciences.

[34]  F. Gago,et al.  The dual role of thymidine phosphorylase in cancer development and chemotherapy , 2009, Medicinal research reviews.

[35]  Alexander Brill,et al.  Platelet‐derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP‐2 production , 2009, International journal of cancer.

[36]  P. Elwood,et al.  Aspirin, salicylates, and cancer , 2009, The Lancet.

[37]  Bethan Psaila,et al.  The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.

[38]  H. Rosen,et al.  Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules , 2009, Nature Reviews Drug Discovery.

[39]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[40]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[41]  T. Yip,et al.  Platelets actively sequester angiogenesis regulators. , 2009, Blood.

[42]  F. Luscinskas,et al.  Neutrophil Recruitment under Shear Flow: It's All about Endothelial Cell Rings and Gaps , 2009, Microcirculation.

[43]  M. Cybulsky,et al.  Role of α4β1 Integrins in Chemokine‐Induced Monocyte Arrest under Conditions of Shear Stress , 2009, Microcirculation.

[44]  A. Varki,et al.  Selectins, Heparins, and Cancer: Rationale for Clinical Trials. , 2008 .

[45]  J. Irving,et al.  In Childhood ALL, Both Blasts with a CD20(-/Low) and a CD20(High) Immunophenotype, Have the Ability to Transfer the Leukemia Onto Immune-Deficient NOD/Scid Y-/- Mice , 2008 .

[46]  S. Rafii,et al.  Platelets, petechiae, and preservation of the vascular wall. , 2008, The New England journal of medicine.

[47]  I. Bauerfeind,et al.  Platelet-derived microparticles and coagulation activation in breast cancer patients , 2008, Thrombosis and Haemostasis.

[48]  H. Versteeg,et al.  Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. , 2008, Cancer research.

[49]  D. Wagner,et al.  Platelet granule secretion continuously prevents intratumor hemorrhage. , 2008, Cancer research.

[50]  L. Borsig.  The role of platelet activation in tumor metastasis , 2008, Expert review of anticancer therapy.

[51]  C. Silliman,et al.  Oncogenic and Angiogenic Growth Factors Accumulate during Routine Storage of Apheresis Platelet Concentrates , 2008, Clinical Cancer Research.

[52]  S. Karpatkin,et al.  Twist is required for thrombin-induced tumor angiogenesis and growth. , 2008, Cancer research.

[53]  J. Palumbo.  Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination. , 2008, Seminars in thrombosis and hemostasis.

[54]  N. Mackman.  Triggers, targets and treatments for thrombosis , 2008, Nature.

[55]  K. Kaushansky.  Historical review: megakaryopoiesis and thrombopoiesis. , 2008, Blood.

[56]  J. Folkman,et al.  Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. , 2008, Blood.

[57]  T. Yip,et al.  Platelet-associated PF-4 as a biomarker of early tumor growth. , 2008, Blood.

[58]  Konstantinos Konstantopoulos,et al.  The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion. , 2008, American journal of physiology. Cell physiology.

[59]  M. Okada,et al.  Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs , 2008, Oncogene.

[60]  D. Mosher,et al.  Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma , 2008, Journal of leukocyte biology.

[61]  Ø. Bruserud,et al.  Platelet functions and clinical effects in acute myelogenous leukemia , 2007, Thrombosis and Haemostasis.

[62]  G. Davı̀,et al.  Platelet activation and atherothrombosis. , 2007, The New England journal of medicine.

[63]  Gary H Lyman,et al.  American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  G. Raskob,et al.  American Society of Clinical Oncology 2007 Clinical Practice Guideline Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer. , 2007, Journal of oncology practice.

[65]  M. Wojtukiewicz,et al.  Inhibition of platelet function: does it offer a chance of better cancer progression control? , 2007, Seminars in thrombosis and hemostasis.

[66]  Shaker A Mousa,et al.  The role of tissue factor pathway inhibitor in tumor growth and metastasis. , 2007, Seminars in thrombosis and hemostasis.

[67]  Roberto Pili,et al.  Platelets Take Up the Monoclonal Antibody Bevacizumab , 2007, Clinical Cancer Research.

[68]  A. Varki.  Trousseau's syndrome: multiple definitions and multiple mechanisms. , 2007, Blood.

[69]  F. Erdemir,et al.  Clinical Significance of Platelet Count in Patients with Renal Cell Carcinoma , 2007, Urologia Internationalis.

[70]  M. Bar‐eli,et al.  Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor , 2007, Cancer and Metastasis Reviews.

[71]  R. Alon,et al.  Integrin modulation and signaling in leukocyte adhesion and migration , 2007, Immunological reviews.

[72]  Zhiwei Hu,et al.  Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. , 2007, Blood.

[73]  F. Lohr,et al.  Preoperative thrombocytosis predicts poor survival in patients with glioblastoma. , 2007, Neuro-oncology.

[74]  D. Peeper,et al.  Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. , 2007, Cancer research.

[75]  Z. Ruggeri,et al.  Activation of Platelet Function Through G Protein–Coupled Receptors Platelets As Immune Cells: Bridging Inflammation and Cardiovascular Disease In Vivo Thrombus Formation in Murine Models Clinical Aspects of Platelet Inhibitors and Thrombus Formation Adhesion Mechanisms in Platelet Function , 2007 .

[76]  Masahiko Zuka,et al.  Platelet glycoprotein Ibα supports experimental lung metastasis , 2007, Proceedings of the National Academy of Sciences.

[77]  C. Weber,et al.  Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease , 2007, Circulation research.

[78]  S. Eichinger,et al.  Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer , 2006, Thrombosis and Haemostasis.

[79]  M. Gultekin,et al.  The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma. , 2006, Gynecologic oncology.

[80]  A. Nagler,et al.  Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells. , 2006, Cancer research.

[81]  S. Karpatkin,et al.  Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. , 2006, Cancer cell.

[82]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[83]  M. Ratajczak,et al.  Enhancing effect of platelet‐derived microvesicles on the invasive potential of breast cancer cells , 2006, Transfusion.

[84]  Fan Zhang,et al.  Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes , 2006, Nature Medicine.

[85]  R. Bertina,et al.  Microparticle‐associated tissue factor activity: a link between cancer and thrombosis? , 2007, Journal of thrombosis and haemostasis : JTH.

[86]  J. Quigley,et al.  Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.

[87]  Yiling Lu,et al.  Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. , 2006, Cancer cell.

[88]  K. Bensalah,et al.  Prognostic value of thrombocytosis in renal cell carcinoma. , 2006, The Journal of urology.

[89]  D Meyer,et al.  Increased metastatic potential of tumor cells in von Willebrand factor‐deficient mice , 2006, Journal of thrombosis and haemostasis : JTH.

[90]  W. Ruf,et al.  Thrombin generation and the pathogenesis of cancer. , 2006, Seminars in thrombosis and hemostasis.

[91]  R. Jain,et al.  Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[92]  D. Taverna,et al.  A Direct Test of Potential Roles for β3 and β5 Integrins in Growth and Metastasis of Murine Mammary Carcinomas , 2005 .

[93]  R. Hynes,et al.  Therapeutic expression of the platelet-specific integrin, αIIbβ3, in a murine model for Glanzmann thrombasthenia , 2005 .

[94]  M. Arnaout,et al.  Integrin structure, allostery, and bidirectional signaling. , 2005, Annual review of cell and developmental biology.

[95]  M. Watsky,et al.  LPA and S1P increase corneal epithelial and endothelial cell transcellular resistance. , 2005, Investigative ophthalmology & visual science.

[96]  M. Shoup,et al.  Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas. , 2005, American journal of surgery.

[97]  Anna Janowska-Wieczorek,et al.  Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer , 2005, International journal of cancer.

[98]  J. Wallace,et al.  Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[99]  J. Massagué,et al.  Platelets and metastasis revisited: a novel fatty link. , 2004, The Journal of clinical investigation.

[100]  P. Clézardin,et al.  Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. , 2004, The Journal of clinical investigation.

[101]  Kim D Janda,et al.  Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[102]  Ruth J. Muschel,et al.  Coagulation Facilitates Tumor Cell Spreading in the Pulmonary Vasculature during Early Metastatic Colony Formation , 2004, Cancer Research.

[103]  P. Jurasz,et al.  Platelet–cancer interactions: mechanisms and pharmacology of tumour cell‐induced platelet aggregation , 2004, British journal of pharmacology.

[104]  Liang Hu,et al.  Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis. , 2004, Blood.

[105]  A. Khorana,et al.  Pancreatic cancer and thromboembolic disease. , 2004, The Lancet. Oncology.

[106]  S. Coughlin,et al.  Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. , 2004, Blood.

[107]  J. Mallet,et al.  Recent advances in understanding serotonin regulation of cardiovascular function. , 2004, Trends in molecular medicine.

[108]  R. Henschler,et al.  Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. , 2004, Cancer research.

[109]  G. Cagney,et al.  Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. , 2004, Blood.

[110]  C. Poole,et al.  Thrombosis and cancer , 2004, Nature Reviews Clinical Oncology.

[111]  M. Wojtukiewicz,et al.  Platelets and angiogenesis in malignancy. , 2004, Seminars in thrombosis and hemostasis.

[112]  A. Khorana.  Malignancy, thrombosis and Trousseau: the case for an eponym , 2003, Journal of thrombosis and haemostasis : JTH.

[113]  M. Tomasson,et al.  Platelet and osteoclast β3 integrins are critical for bone metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[114]  B. Felding-Habermann,et al.  Targeting Tumor Cell-Platelet Interaction in Breast Cancer Metastasis , 2003, Pathophysiology of Haemostasis and Thrombosis.

[115]  S. Mousa,et al.  Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454 , 2003, Thrombosis and Haemostasis.

[116]  A. Saven,et al.  Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[117]  J. Garcia,et al.  Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[118]  Viqar Zaman,et al.  The End Game , 2003 .

[119]  Michael Gnant,et al.  Impact of pretreatment thrombocytosis on survival in primary breast cancer , 2003, Thrombosis and Haemostasis.

[120]  K. Messmer,et al.  Platelet-endothelial interaction in tumor angiogenesis and microcirculation. , 2003, Blood.

[121]  D. Jackson,et al.  Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. , 2002, Cancer research.

[122]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[123]  D. Praticò,et al.  Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. , 2002, Experimental hematology.

[124]  Ajit Varki,et al.  Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[125]  Wei Huang,et al.  Role of thrombin signalling in platelets in haemostasis and thrombosis , 2001, Nature.

[126]  David R. Nadeau,et al.  Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[127]  J W Smith,et al.  Integrin activation controls metastasis in human breast cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[128]  G. Lip,et al.  Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[129]  T. Ohmori,et al.  Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells , 2000 .

[130]  T. Bugge,et al.  Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. , 2000, Blood.

[131]  O. McCarty,et al.  Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. , 2000, Blood.

[132]  A. Varki,et al.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. , 1999, The American journal of pathology.

[133]  B. Echtenacher,et al.  Lysis of tumor cells by natural killer cells in mice is impeded by platelets. , 1999, Cancer research.

[134]  J. Folkman,et al.  Involvement of platelets in tumour angiogenesis? , 1998, The Lancet.

[135]  A. Varki,et al.  P-selectin deficiency attenuates tumor growth and metastasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[136]  M. Skobe,et al.  Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization , 1998, Nature Medicine.

[137]  Stefan Offermanns,et al.  Defective platelet activation in Gαq-deficient mice , 1997, Nature.

[138]  S. Rafii,et al.  Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[139]  Zaverio M. Ruggeri,et al.  Role of 3 Integrins in Melanoma Cell Adhesion to Activated Platelets under Flow (*) , 1996, The Journal of Biological Chemistry.

[140]  S. Tebbutt,et al.  Extrinsic-pathway activation in cancer with high factor Vlla and tissue factor , 1995, The Lancet.

[141]  R. Abbate,et al.  Platelet activation and platelet lipid composition in pulmonary cancer. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.

[142]  Acknowledgements , 1992, Experimental Gerontology.

[143]  T S Edgington,et al.  Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[144]  P. Kuna,et al.  RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. , 1992, Journal of immunology.

[145]  I. Fidler,et al.  Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. , 1991, Cancer research.

[146]  Thomas E. Moritz,et al.  The Platelet Count in Carcinoma of the Lung and Colon , 1990, Thrombosis and Haemostasis.

[147]  G. Blomqvist,et al.  The role of calcium channels and serotonin (5-HT2) receptors for tumour cell lodgement in the liver , 1989, Clinical & Experimental Metastasis.

[148]  G. Kōsaki,et al.  Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells. , 1989, Cancer research.

[149]  S. Karpatkin,et al.  Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. , 1988, The Journal of clinical investigation.

[150]  Bonnie F. Sloane,et al.  Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[151]  A. Dahlström,et al.  The importance of 5‐HT for tumor cell lodgement in the liver , 1984, International journal of cancer.

[152]  A. Ketcham,et al.  Electron microscopic observations on formation of pulmonary metastases. , 1975, The Journal of surgical research.

[153]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[154]  J Folkman,et al.  Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.

[155]  E. Fraser,et al.  Sequence of events in experimental metastases of Walker 256 tumor: light, immunofluorescent, and electron microscopic observations. , 1971, Journal of the National Cancer Institute.

[156]  C. Stewart,et al.  Antimetastatic effects associated with platelet reduction. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[157]  R. Strieter,et al.  CXC chemokines in cancer angiogenesis and metastases. , 2010, Advances in cancer research.

[158]  I. Fichtner,et al.  Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions , 2009, Clinical & Experimental Metastasis.

[159]  Klaus Ley,et al.  Mechanisms and consequences of neutrophil interaction with the endothelium. , 2008, The American journal of pathology.

[160]  J. Nieva,et al.  Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. , 2008, Thrombosis research.

[161]  W. Ruf.  Tissue factor and PAR signaling in tumor progression. , 2007, Thrombosis research.

[162]  J. Degen,et al.  Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis. , 2007, Thrombosis research.

[163]  C. Denis,et al.  Role of von Willebrand factor in tumor metastasis. , 2007, Thrombosis research.

[164]  J. Degen,et al.  Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. , 2005, Blood.

[165]  H. K. Kim,et al.  Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. , 2003, European journal of cancer.

[166]  H. Verheul,et al.  Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[167]  Stephen Pulman,et al.  Building the Framework , 1996 .

[168]  K. Honn,et al.  Platelets and Cancer Metastasis: More Than an Epiphenomenon , 1992, Seminars in thrombosis and hemostasis.

[169]  S. Karpatkin,et al.  Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. , 1991, The Journal of clinical investigation.

[170]  H. Dvorak,et al.  Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. , 1991, The American journal of pathology.

[171]  P. Mehta.  Potential role of platelets in the pathogenesis of tumor metastasis. , 1984, Blood.

[172]  J. C. Vuletin,et al.  A Light and Electron Microscopic Study , 1976 .